Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK, and Pyk2.Conteltinib exhibits significant inhibition of FAK, overcomes hypoxia-mediated sorafenib resistance in hepatocellular carcinoma through inhibition of YAP signaling, and can be used in advanced ALK-positive non-small-cell lung cancer and lymphoma.
Molecular Weight:
635.82
Purity:
98.12%
CAS Number:
[1384860-29-0]
Formula:
C32H45N9O3S
Target:
FAK|||ALK|||PYK2
T14997
* VAT and and shipping costs not included. Errors and price changes excepted